Skip to main content
logo
Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
38.06
-0.43 (-1.12%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Celldex Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,9871,8071,6772,2162,1041,806
Market Cap Growth
97.25%7.76%-24.32%5.35%16.51%160.23%
Enterprise Value
2,5381,292956.761,7991,8041,402
Last Close Price
38.0627.1625.2739.6644.5738.64

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3453.651169.89238.93322.00892.55388.23
PB Ratio
5.553.432.255.166.454.30
P/TBV Ratio
5.903.612.264.786.994.22

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2933.94836.55136.29261.41765.30301.44

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.010.00
Net Debt / Equity Ratio
-0.98-0.98-0.96-0.97-0.92-0.96
Net Debt / EBITDA Ratio
1.471.813.762.752.675.92
Net Debt / FCF Ratio
1.982.414.513.822.846.49
Asset Turnover
0.000.000.010.020.010.01
Quick Ratio
8.7810.2118.3813.6916.4124.71
Current Ratio
8.9210.4918.9113.8717.0724.86
Return on Equity (ROE)
-57.69%-40.62%-26.84%-37.45%-30.13%-22.43%
Return on Assets (ROA)
-56.49%-41.79%-31.01%-37.77%-28.90%-20.87%
Return on Invested Capital (ROIC)
-3080.76%-1487.52%-1011.24%-805.37%-547.47%-377.64%
Return on Capital Employed (ROCE)
-62.33%-44.73%-32.86%-40.21%-30.24%-21.93%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-0.29%-3.15%-32.91%-3.33%-9.37%-44.64%
Total Shareholder Return
-0.29%-3.15%-32.91%-3.33%-9.37%-44.64%
SEC Filings: 10-K · 10-Q